Trevi Therapeutics Stock Analysis

Trevi Stock Analysis Notes

About 81.0% of the company shares are owned by institutional investors. The book value of Trevi Therapeutics was at this time reported as 0.78. The company recorded a loss per share of 0.44. Trevi Therapeutics had not issued any dividends in recent years. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut. Trevi Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people. To find out more about Trevi Therapeutics contact Jennifer Good at 203 304 2499 or learn more at https://www.trevitherapeutics.com.

Trevi Therapeutics Investment Alerts

Trevi Therapeutics Upcoming and Recent Events

Trevi Largest EPS Surprises

View All Earnings Estimates

Trevi Therapeutics Environmental, Social, and Governance (ESG) Scores

Trevi Stock Institutional Investors

Note, although Trevi Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Trevi Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 224.45 M.

Trevi Profitablity

Management Efficiency

Trevi Therapeutics has return on total asset (ROA) of (0.3657) % which means that it has lost $0.3657 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5965) %, meaning that it created substantial loss on money invested by shareholders. Trevi Therapeutics' management efficiency ratios could be used to measure how well Trevi Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.34. The current Return On Capital Employed is estimated to decrease to -0.43. As of now, Trevi Therapeutics' Non Currrent Assets Other are increasing as compared to previous years.

Technical Drivers

As of the 26th of November, Trevi Therapeutics has the Risk Adjusted Performance of 0.0157, semi deviation of 3.66, and Coefficient Of Variation of 10020.51. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Trevi Therapeutics, as well as the relationship between them.

Trevi Therapeutics Price Movement Analysis

Trevi Therapeutics Insider Trading Activities

Trevi Therapeutics Outstanding Bonds

Trevi Therapeutics Predictive Daily Indicators

Trevi Therapeutics Corporate Filings

Trevi Therapeutics Forecast Models

Trevi Therapeutics' time-series forecasting models are one of many Trevi Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Trevi Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Trevi Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Trevi shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Trevi Therapeutics. By using and applying Trevi Stock analysis, traders can create a robust methodology for identifying Trevi entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Trevi analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Trevi analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Trevi Therapeutics stock analysis indicators help investors evaluate how Trevi Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Trevi Therapeutics shares will generate the highest return on investment. By understating and applying Trevi Therapeutics stock analysis, traders can identify Trevi Therapeutics position entry and exit signals to maximize returns.

When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.